New genomic method to track disease outbreaks globally
9h agoen
From the article
Phylo-Plex, a new computational method, has been developed by Wellcome Sanger Institute scientists and their collaborators to allow cost-effective and scalable DNA sequencing of pathogens in laboratories with limited resources. Published today (July 9) in Nature Communications, Phylo-Plex analyzes genetic information from deadly pathogens to help track disease outbreaks, monitor antibiotic resistance and build capacity for research into how infections are spread.
Continue reading on PhysYou might also wanna read
A data-driven look at 10 years of genomics research trends in PLOS Computational Biology
A data-driven reflection on genomics research trends published in PLOS Computational Biology over the past decade (2017-2026). The author, a
journals.plos.org·4d agoEpidemiology and characteristics of cases with monkeypox virus clade I in the WHO European Region, 2024 to 2025
Eurosurveillance·21d ago
Phage Explorer: Open-Source Software for Bacteriophage Genome Visualization and Analysis
Phage Explorer is a free, open-source software tool for visualizing and analyzing bacteriophage genomes. It provides color-coded DNA and ami
phage-explorer.org·5mo ago
The Evolution of DNA Sequencing: From Sanger to Nanopore Technology
This article provides a comprehensive visual guide to DNA sequencing technologies, tracing the evolution from the Human Genome Project's ini
asimov.press·4mo ago
Rockefeller University researchers discover hundreds of new bacteria and two potential antibiotics in soil using DNA sequencing
Researchers at Rockefeller University have developed a method to access the genetic material of soil bacteria that cannot be cultured in a l
rockefeller.edu·9mo ago
Wastewater sequencing reveals SARS-CoV-2 genetic diversity linked to community transmission levels
This article presents a scientific study on the genetic variability of SARS-CoV-2 detected in wastewater samples and its correlation with co
doi.org·20d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.